These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 30029203)

  • 1. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells.
    Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
    Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
    Chen W; Zhang L; Liu S; Chen C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds.
    Malla R; Jyosthsna K; Rani G; Purnachandra Nagaraju G
    Int Immunopharmacol; 2024 Sep; 138():112613. PubMed ID: 38959542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion.
    Ojo D; Wei F; Liu Y; Wang E; Zhang H; Lin X; Wong N; Bane A; Tang D
    Curr Med Chem; 2015; 22(19):2360-74. PubMed ID: 25882671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
    Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
    PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
    Semenza GL
    Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
    Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
    Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
    Liang ZM; Chen Y; Luo ML
    Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
    Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
    Xiang L; Semenza GL
    Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
    Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
    Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Breast Cancer Stem Cells Traits and Drug Resistance.
    Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
    Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.